Scholtysik G
Naunyn Schmiedebergs Arch Pharmacol. 1987 Jun;335(6):692-6. doi: 10.1007/BF00166988.
Electrophysiological effects of the 5-HT3 receptor antagonist ICS 205-930 [(3 alpha-tropanyl)-1H-indole-3-carboxylic acid ester] were investigated in guinea pig isolated heart preparations. ICS 205-930 prolonged the functional refractory period and decreased the force of contraction in left driven atria. It decreased spontaneous beating rate in right atria. These effects were concentration dependent between 3 X 10(-6) and 10(-4) mol/l of ICS 205-930. In fast action potentials of papillary muscles ICS 205-930 concentration-dependently depressed Vmax and prolonged the action potential duration (APD) between 10(-6) and 10(-5) mol/l. The action potential amplitude (APA) and the resting membrane potential (RMP) remained unchanged. In papillary muscles partially depolarized by high K+ (22 mmol/l) and reactivated by high voltage stimulation, slow response APs were prolonged by ICS 205-930 10(-6) to 3 X 10(-5) mol. Vmax, APA and RMP were not affected. Similar effects on APD were obtained with sotalol (3 X 10(-5) mol/l), an inhibitor of outward K+ current. The slow-APD prolongation induced by ICS 205-930 as well as by sotalol was reversed by BRL 34915 (6-cyano-3,4-dihydro-2,2-dimethyltrans-4-(2-oxo-1-pyrrolidyl )-2H-benzo[b]pyran-3-ol), known to open K+ channels. BRL 34915 alone reduced slow-APD stereoselectively. The results suggest that ICS 205-930 may inhibit and BRL 34915 may stimulate the K+ conductance of guinea pig myocardial cell membranes.(ABSTRACT TRUNCATED AT 250 WORDS)
在豚鼠离体心脏标本中研究了5-羟色胺3(5-HT3)受体拮抗剂ICS 205-930 [(3α-托烷)-1H-吲哚-3-羧酸酯]的电生理效应。ICS 205-930延长了功能性不应期,并降低了左驱动心房的收缩力。它降低了右心房的自发搏动率。在3×10⁻⁶至10⁻⁴mol/L的ICS 205-930浓度范围内,这些效应呈浓度依赖性。在乳头肌的快动作电位中,在10⁻⁶至10⁻⁵mol/L之间,ICS 205-930浓度依赖性地降低Vmax并延长动作电位持续时间(APD)。动作电位幅度(APA)和静息膜电位(RMP)保持不变。在被高钾(22 mmol/L)部分去极化并通过高压刺激重新激活的乳头肌中,慢反应动作电位被10⁻⁶至3×10⁻⁵mol的ICS 205-930延长。Vmax、APA和RMP不受影响。用索他洛尔(3×10⁻⁵mol/L,一种外向钾电流抑制剂)对APD也获得了类似的效应。由ICS 205-930以及索他洛尔诱导的慢APD延长可被已知能开放钾通道的BRL 34915(6-氰基-3,4-二氢-2,2-二甲基反式-4-(2-氧代-1-吡咯烷基)-2H-苯并[b]吡喃-3-醇)逆转。单独使用BRL 34915可立体选择性地降低慢APD。结果表明,ICS 205-930可能抑制而BRL 34915可能刺激豚鼠心肌细胞膜的钾电导。(摘要截短于250字)